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Introduction: For the application of protons in radio-
therapy a constant relative biological effectiveness (RBE)
of 1.1 is considered in the treatment planning procedure.
However, the results of in-vitro experiments [1, 2] show
an increase of the RBE towards the distal end of a proton
spread out Bragg peak (SOBP). RBE predictions of the lo-
cal effect model (LEM IV; [3]) are consistent with these
experimental data [5]. Due to the fact that the LET is fur-
ther increasing in the declining edge of the SOBP the RBE
is higher than the clinically used value of 1.1. As a con-
sequence, this increased RBE leads to an extension of the
biologically effective proton range. In the presented work
we investigate the influence of the physical dose fall-off on
the RBE and the biologically effective range of the proton
beam.
Methods: Since the most distal proton Bragg peak
that contributes to the proton SOBP determines the gra-
dient of the dose fall-off, the treatment planning software
TRiP98 [4] was used to calculate the physical and RBE-
weighted depth dose distribution of monoenergetic proton
Bragg peaks with energies ranging from 71 to 220 MeV.
With increasing initial energy of the proton beam the distal
dose fall-off gets broader, i.e. the gradient increases, due to
range straggling in the absorber material. The correspond-
ing RBE-weighted dose was calculated based on the RBE
predictions of the LEM IV. The biological range extension
and the RBE at maximum RBE-weighted dose were inves-
tigated for different dose-levels of 1-10 Gy absorbed dose
and two different α/β-ratios of 2 Gy and 10 Gy, respec-
tively. The biological range extension is defined as the
difference of the RBE-weighted doses based on a constant
RBE of 1.1 and the LEM IV based RBE at the 80 % iso-
dose.
Results: Figure 1a illustrates the RBE at maximum
RBE-weighted dose in the SOBP in dependence on the gra-
dient of the 80-20 % dose fall-off. The RBE at maximum
RBE-weighted dose is decreasing with increasing gradient
of the distal dose fall-off. In contrast, the biological range
difference is increasing with the flattening of the distal dose
fall-off (fig. 1b). Further, the RBE and thus the biological
range difference is larger for α/β-ratios of 2 Gy compared
to 10 Gy and decreases with increasing dose [5]. The re-
sults show that the the gradient of the distal dose fall-off
opposingly affects the RBE-weighted dose at the distal end
of the SOBP and the biological range extension of the pro-
ton beam.
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Figure 1: RBE at maximum RBE weighted dose (a) and
biological range difference (b) in dependence on the distal
penumbra for a α/β-ratios of 2 Gy and different physical
dose levels of 1, 3, 6, and 10 Gy. The data points represent
the distal fall-off for energies from 71 to 220 MeV.
Conclusion: The increasing RBE at the distal end and
the biological range extension are influenced by both bio-
logical factors like the α/β-ratios of the cell or tissue type
and physical factors like the gradient of the distal dose fall
off. Hence, the initial beam energy and the depth modu-
lation system used to create the SOBP mainly affect the
balance between maximum RBE-weighted dose and bio-
logical range extension.
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